Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs ALHC✓SelectedUSD · ALHCGSK vs ALHC performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs ALHC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
ALHC return
-66.8%
Excess return
+113.5%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioALHCExcessAlpha
1D-0.1%+1.5%-1.6%-0.1%
7D-1.3%+2.8%-4.1%-1.4%
30D+2.7%-9.8%+12.5%+2.9%
3M+2.7%-46.5%+49.2%+4.0%
6M+3.3%-52.5%+55.8%+4.6%
YTD+6.5%-62.2%+68.6%+8.1%
1Y+10.7%-54.8%+65.4%+12.0%
3Y+64.4%+13.1%+51.3%+61.3%
5Y+46.7%-67.3%+114.0%+50.6%
All+46.7%-66.8%+113.5%+50.6%

Cumulative growth

Daily Returns

Daily percentage return beside ALHC.

Daily Out/Under-Performance

Portfolio return minus ALHC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ALHC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded ALHC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling